@inproceedings{inproceedings, title  = {{161 52-Week Laboratory Safety Findings From an Open-Label Extension Study of Dupilumab in Adolescent Patients With Atopic Dermatitis (LIBERTY AD PED-OLE)}},

 url = {{}},

 year = {{2021}},

 month = {{10}},

 author = {{Cork MJ and Lockshin B and Blauvelt A and Chen Z and Khokhar FA and Bansal A and Prescilla R}},

 doi = {{10.1136/archdischild-2021-europaediatrics.161}},

 pages = {{a68.2-a6a69}},

 note = {{Accessed on 2024/12/22}}}